Announcing Integration with BEKHealth

Devana Solutions and BEKHealth combine Site Performance Metrics with Protocol-to-Patient Matching to Transform Clinical Trial Feasibility.

Click to read Outsourcing-Pharma’s article about this exciting announcement.

[Chapel Hill, NC – New York, NY] – August 12, 2020 The clinical trials industry quest for reliable, predictable trial performance just made a major leap forward with the announcement today that BEKHealth and Devana Solutions have finalized an agreement to integrate their platforms. The two companies, makers of the most innovative technology solutions targeting clinical research organizations are confident their combined technology will be a game-changer for research sites, Sponsors and CROs seeking to align the right study with the right sites with the right patients.

“The combination of a site’s historical performance data with a highly precise feasibility AI solution which can cover >90% of study criteria increases the reliability of site selection exponentially”, stated Jason Baumgartner, CEO of BEKHealth.  “Historical performance is extremely valuable in predicting performance yet alone can lead to disparities and missed opportunities for customers to uncover new patient populations. With Devana’s IGNITE platform having taken off with the leading research organizations, we see this as a natural extension of our platform.”

“A couple of leaders in the site sector whom Jason and I both respect immensely brought us together initially” continued Barry Lake, Devana Solutions CEO & Co-Founder, “and the prospect of combining BEKHealth’s platform with Devana IGNITE’s automation of site startup workflows and capture and analytics of trial performance metrics will be revolutionary for Sponsors and CROs seeking predictability and reliability of trial and site performance.”

With a joint commercialization agreement in place, BEKHealth and Devana Solutions are already collaborating on client and prospect referrals for demonstrations of the systems for clinical trial stakeholders including site organizations, Sponsors and CROs while the engineers have begun the work of integrating the platforms in advance of a projected roll-out of the combined solution in Q4.

ABOUT BEKHEALTH:

BEKHealth was founded under the belief that accelerating the research of innovative medicines can have a profound impact on human health. The company believes clinical research sites and research personnel have been underserved from a technology deployment and modern workflow perspective. The BEKHealth platform offers artificial intelligence (AI) solutions to comprehensively review patient medical histories, automatically match patients to complex trial protocols, and help sites recruit more patients in less time For more information visit http://bekhealth.com/about/.

ABOUT DEVANA SOLUTIONS:

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce clinical trial cycle time and costs to deliver new therapies to patients. Devana Solutions offers three platforms, IGNITE, PROPEL, and IQ for sponsors and CROs, to provide historical and real-time data capture, aggregation and display to drug development stakeholders. For more information call (877) DEVANA-2 or visit http://devanasolutions.com.